Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Genitourinary 1

Conditions

Sezary Syndrome 1Renal Insufficiency 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Kidney Failure, Chronic 1

Interventions

glucarpidase 2safinamide 1sacubitril and valsartan sodium hydrate drug combination 1ripretinib 1mirabegron 1gamma-Glutamyl Hydrolase 1Sitagliptin Phosphate 1Rituximab 1Methotrexate 1Leucovorin 1Lenalidomide 1Eplerenone 1Duration of Therapy 1Cyclophosphamide 1Cilengitide 1Carboxypeptidases 1Bendamustine Hydrochloride 1Azacitidine 13-(5-amino-2-methyl-4-oxoquinazolin-3(4H)-yl)piperidine-2,6-dione 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Insufficiency × Duration of Therapy × Lymphoid × Clear all
NCT00418366 2015-08-19

A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

Merck Sharp & Dohme LLC

Phase 1 Completed
24 enrolled
GenitourinaryLymphoid

Kidney Failure, Chronic, Lymphoma, Follicular, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡